Is PDS Biotechnology Corporation (PDSB) a Buy, Sell, or Hold?
NASDAQ : PDSB
PDS Biotechnology Corporation — Insider Trades
$0.2623 USD
$0.01 (2.14%)
- Volume
- 1.56M
- Average Volume
- 795.78K
- Market Capitalization
- $14.67M
- P/E Ratio
- -0.39
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $1.55
- Year Low
- $0.23
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.26
Insider Activity Summary (Last 12 Months)
Insiders Buying
17
Insiders Selling
0
Amount of Insider Selling
-$
PDSB Insider Buying/Selling by Quarter
PDSB Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| BEDU-ADDO FRANK | director, officer: President/CEO | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| CONN GREGORY | officer: Chief Scientific Officer | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| Shepard Kirk V. | officer: Chief Medical Officer | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| Boesgaard Lars | officer: Chief Financial Officer | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| Brown Spencer D. | officer: Senior VP, General Counsel | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| Toutain Stephan | officer: Chief Operating Officer | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| Freitag Gregory Gene | director | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| Iliev Ilian | director | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| Ali-Jackson Kamil | director | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| BRAWLEY OTIS W | director | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| Glover Stephen C. | director | 2026-01-12 | A-Award | 0.98 | 2026-03-03 |
| BEDU-ADDO FRANK | director, officer: President/CEO | 2024-02-28 | A-Award | 5.87 | 2025-07-25 |
| BEDU-ADDO FRANK | director, officer: President/CEO | 2025-06-12 | A-Award | 1.79 | 2025-07-25 |
| Shepard Kirk V. | officer: Chief Medical Officer | 2025-06-12 | A-Award | 1.79 | 2025-07-25 |
| Brown Spencer D. | officer: Senior VP, General Counsel | 2025-06-12 | A-Award | 1.79 | 2025-07-25 |
| Brown Spencer D. | officer: Senior VP, General Counsel | 2024-02-28 | A-Award | 5.87 | 2025-07-25 |
| Boesgaard Lars | officer: Chief Financial Officer | 2025-06-12 | A-Award | 1.79 | 2025-07-25 |
| CONN GREGORY | officer: Chief Scientific Officer | 2024-02-28 | A-Award | 5.87 | 2025-07-25 |
| CONN GREGORY | officer: Chief Scientific Officer | 2025-06-12 | A-Award | 1.79 | 2025-07-25 |
| Toutain Stephan | officer: Chief Operations Officer | 2025-06-12 | A-Award | 1.79 | 2025-07-25 |
| BRAWLEY OTIS W | director | 2025-06-11 | A-Award | 1.75 | 2025-06-11 |
| Ali-Jackson Kamil | director | 2025-06-11 | A-Award | 1.75 | 2025-06-11 |
| Freitag Gregory Gene | director | 2025-06-11 | A-Award | 1.75 | 2025-06-11 |
| Iliev Ilian | director | 2025-06-11 | A-Award | 1.75 | 2025-06-11 |
| Glover Stephen C. | director | 2025-06-11 | A-Award | 1.75 | 2025-06-11 |
| Freitag Gregory Gene | director | 2025-02-28 | P-Purchase | 1.66 | 2025-03-03 |
| Freitag Gregory Gene | director | 2025-02-28 | P-Purchase | 1.53 | 2025-03-03 |
| Glover Stephen C. | director | 2025-02-28 | P-Purchase | 1.66 | 2025-03-03 |
| Glover Stephen C. | director | 2025-02-28 | P-Purchase | 1.53 | 2025-03-03 |
| Freitag Gregory Gene | director | 2024-06-24 | A-Award | 2.86 | 2024-06-25 |
| Glover Stephen C. | director | 2024-06-24 | A-Award | 2.86 | 2024-06-25 |
| SYKES RICHARD | director | 2024-06-24 | A-Award | 2.86 | 2024-06-25 |
| Iliev Ilian | director | 2024-06-24 | A-Award | 2.86 | 2024-06-25 |
| BRAWLEY OTIS W | director | 2024-06-24 | A-Award | 2.86 | 2024-06-25 |
| Ali-Jackson Kamil | director | 2024-06-24 | A-Award | 2.86 | 2024-06-25 |
| Toutain Stephan | officer: Chief Operations Officer | 2024-05-01 | A-Award | 3.61 | 2024-05-02 |
| Toutain Stephan | 2024-05-01 | 0 | 2024-05-02 | ||
| Shepard Kirk V. | officer: Chief Medical Officer | 2024-01-22 | A-Award | 4.49 | 2024-01-23 |
| Shepard Kirk V. | 2024-01-22 | 0 | 2024-01-23 | ||
| Boesgaard Lars | officer: Chief Financial Officer | 2023-12-04 | A-Award | 5.28 | 2023-12-04 |
| Boesgaard Lars | 2023-12-04 | 0 | 2023-12-04 | ||
| Freitag Gregory Gene | director | 2023-07-14 | A-Award | 5.13 | 2023-07-17 |
| BRAWLEY OTIS W | director | 2023-07-14 | A-Award | 5.13 | 2023-07-17 |
| Ali-Jackson Kamil | director | 2023-07-14 | A-Award | 5.13 | 2023-07-17 |
| SYKES RICHARD | director | 2023-07-14 | A-Award | 5.13 | 2023-07-17 |
| Glover Stephen C. | director | 2023-07-14 | A-Award | 5.13 | 2023-07-17 |
| Iliev Ilian | director | 2023-07-14 | A-Award | 5.13 | 2023-07-17 |
| Brown Spencer D. | director: Senior VP, General Counsel | 2023-01-05 | A-Award | 0 | 2023-01-06 |
| HILL MATTHEW C | director: Chief Financial Officer | 2023-01-05 | A-Award | 0 | 2023-01-06 |
| CONN GREGORY | director: Chief Scientific Officer | 2023-01-05 | A-Award | 0 | 2023-01-06 |
| BEDU-ADDO FRANK | director: President/CEO | 2023-01-05 | A-Award | 0 | 2023-01-06 |
| WOOD LAUREN | director: Chief Medical Officer | 2023-01-05 | A-Award | 0 | 2023-01-06 |
| HILL MATTHEW C | officer: Chief Financial Officer | 2023-01-05 | A-Award | 11.61 | 2023-01-06 |
| BEDU-ADDO FRANK | director: President/CEO | 2022-12-02 | M-Exempt | 6.57 | 2022-12-02 |
| BEDU-ADDO FRANK | director: President/CEO | 2022-12-02 | F-InKind | 9.78 | 2022-12-02 |
| BEDU-ADDO FRANK | director: President/CEO | 2022-12-02 | M-Exempt | 0 | 2022-12-02 |
| Glover Steve C | director | 2022-06-28 | A-Award | 3.9 | 2022-06-29 |
| Glover Steve C | director: | 2022-06-28 | A-Award | 0 | 2022-06-29 |
| Iliev Ilian | director | 2022-06-28 | A-Award | 3.9 | 2022-06-29 |
| Iliev Ilian | director: | 2022-06-28 | A-Award | 0 | 2022-06-29 |
| BRAWLEY OTIS W | director: | 2022-06-28 | A-Award | 0 | 2022-06-29 |
| Freitag Gregory Gene | director | 2022-06-28 | A-Award | 3.9 | 2022-06-29 |
| Freitag Gregory Gene | director: | 2022-06-28 | A-Award | 0 | 2022-06-29 |
| SYKES RICHARD | director | 2022-06-28 | A-Award | 3.9 | 2022-06-29 |
| SYKES RICHARD | director: | 2022-06-28 | A-Award | 0 | 2022-06-29 |
| Ali-Jackson Kamil | director: | 2022-06-28 | A-Award | 0 | 2022-06-29 |
| Brown Spencer D. | director: Senior VP, General Counsel | 2022-06-02 | A-Award | 0 | 2022-06-03 |
| Brown Spencer D. | 2022-06-01 | 0 | 2022-06-03 | ||
| CONN GREGORY | 2022-01-19 | A-Award | 6.28 | 2022-01-20 | |
| BEDU-ADDO FRANK | 2022-01-19 | A-Award | 6.28 | 2022-01-20 | |
| WOOD LAUREN | officer: Chief Medical Officer | 2022-01-19 | A-Award | 6.28 | 2022-01-20 |
| WOOD LAUREN | director: Chief Medical Officer | 2022-01-19 | A-Award | 6.28 | 2022-01-20 |
| HILL MATTHEW C | 2021-12-13 | P-Purchase | 9 | 2021-12-14 | |
| HILL MATTHEW C | 2021-12-13 | P-Purchase | 9 | 2021-12-14 | |
| HILL MATTHEW C | 2021-12-13 | P-Purchase | 8.9 | 2021-12-14 | |
| HILL MATTHEW C | 2021-12-13 | P-Purchase | 9 | 2021-12-14 | |
| HILL MATTHEW C | 2021-10-19 | A-Award | 12.03 | 2021-10-20 | |
| HILL MATTHEW C | 2021-10-18 | 0 | 2021-10-20 | ||
| Trochimiuk Janetta | 2021-09-30 | 2.88 | 2021-10-12 | ||
| Trochimiuk Janetta | 2021-09-30 | 1.45 | 2021-10-12 | ||
| Trochimiuk Janetta | 2021-09-30 | 2.43 | 2021-10-12 | ||
| Bloomquist DeLyle W | 2021-06-16 | P-Purchase | 9.8778 | 2021-06-21 | |
| Bloomquist DeLyle W | 2021-06-16 | M-Exempt | 5.99 | 2021-06-21 | |
| Bloomquist DeLyle W | 2021-06-16 | M-Exempt | 5.99 | 2021-06-21 | |
| BEDU-ADDO FRANK | 2021-06-15 | M-Exempt | 6.57 | 2021-06-17 | |
| BEDU-ADDO FRANK | 2021-06-15 | F-InKind | 12.86 | 2021-06-17 | |
| BEDU-ADDO FRANK | 2021-06-15 | M-Exempt | 6.57 | 2021-06-17 | |
| BRAWLEY OTIS W | 2021-06-17 | A-Award | 9.95 | 2021-06-17 | |
| Glover Steve C | 2021-06-15 | P-Purchase | 8.5 | 2021-06-17 | |
| Glover Steve C | 2021-06-17 | A-Award | 9.95 | 2021-06-17 | |
| Ali-Jackson Kamil | 2021-06-15 | P-Purchase | 8.5 | 2021-06-17 | |
| Ali-Jackson Kamil | 2021-06-17 | A-Award | 9.95 | 2021-06-17 | |
| SYKES RICHARD | 2021-06-17 | A-Award | 9.95 | 2021-06-17 | |
| Iliev Ilian | 2021-06-17 | A-Award | 9.95 | 2021-06-17 | |
| VAN VOORHEES SETH | 2021-06-15 | P-Purchase | 8.5 | 2021-06-17 | |
| Freitag Gregory Gene | 2021-06-15 | P-Purchase | 8.5 | 2021-06-17 | |
| Freitag Gregory Gene | 2021-06-17 | A-Award | 9.95 | 2021-06-17 | |
| VAN VOORHEES SETH | 2021-01-04 | A-Award | 2.28 | 2021-01-06 | |
| VAN VOORHEES SETH | 2021-01-01 | 0 | 2021-01-06 | ||
| CONN GREGORY | 2020-12-08 | A-Award | 2.43 | 2020-12-09 |